Glenmark Pharmaceuticals Ltd 2024 IR
The report highlights Glenmark Pharmaceuticals Limited's performance for FY 2024, showcasing a transition toward complex generics and specialty medicines. A key milestone was the successful divestment of a majority stake in Glenmark Life Sciences, which significantly strengthened the company's financial position to a net cash-positive status. Glenmark advanced its global respiratory portfolio with the expansion of Ryaltris into 34 markets and forged strategic oncology partnerships, including the launch of the Ichnos Glenmark Innovation alliance. On the sustainability front, the company made progress toward its environmental goals, recycling 96% of wastewater in Indian units and achieving zero waste to landfill at five sites.
Company: Glenmark Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2024
Type: IR
Pages: 428
Back to company
Glenmark Pharmaceuticals Ltd
Integrated Annual Report
The report highlights Glenmark Pharmaceuticals Limited's performance for FY 2024, showcasing a transition toward complex generics and specialty medicines. A key milestone was the successful divestment of a majority stake in Glenmark Life Sciences, which significantly strengthened the company's financial position to a net cash-positive status. Glenmark advanced its global respiratory portfolio with the expansion of Ryaltris into 34 markets and forged strategic oncology partnerships, including the launch of the Ichnos Glenmark Innovation alliance. On the sustainability front, the company made progress toward its environmental goals, recycling 96% of wastewater in Indian units and achieving zero waste to landfill at five sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 2023 - Mar 2024
Fiscal Year
2024
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees